Sudarshan Pharma Industries has informed that it enclosed disclosure under Regulation 31(2) of SEBI (Subtsantial Acquisition of Shares and Takeovers) Regulations, 2011 in connection with intimation of pledge.
The above information is a part of company’s filings submitted to BSE.